Free shipping on all orders over $ 500

RS-1

Cat. No. M6148

All AbMole products are for research use only, cannot be used for human consumption.

RS-1 Structure
Size Price Availability Quantity
10mM*1mL in DMSO USD 53  USD53 In stock
1mg USD 21  USD21 In stock
5mg USD 46  USD46 In stock
10mg USD 70  USD70 In stock
25mg USD 126  USD126 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

RS-1 stimulates the binding of hRAD51 to ssDNA. Low-micromolar concentrations of this small molecule enhance DNA binding and result in longer protein–DNA complex lengths. In addition, RS-1 stabilizes the active form of hRAD51 filaments and this is reflected in an enhanced strand assimilation activity.

Protocol (for reference only)
Cell Experiment
Cell lines PC3 cells
Preparation method PC3 cells were treated with 60 μM RS-1 for the indicated times. Cells were collected and fixed in ice cold 70% ethanol for at least 4 hours. Cells were rinsed and stained with 50 μg/ml PI, 50 μg/ml RNAse A in PBS for 20 minutes. Cell cycle distributions were analyzed by flow cytometry using a LSR-II (BD biosciences) cytometer. The percentage of cells in G1, S, and G2/M phases of the cell cycle was determined using FlowJo software.
Concentrations 60 μM
Incubation time 24 h
Animal Experiment
Animal models Athymic nude mice
Formulation 30% DMSO, 35% PEG-400, 35% PBS
Dosages 200 μl
Administration Peritoneal administrations
Chemical Information
Molecular Weight 524.23
Formula C20H16Br2N2O3S
CAS Number 312756-74-4
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Song J, et al. Nat Commun. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency.

[2] Mason JM, et al. Cancer Res. The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.

Related CRISPR/Cas9 Products
BRD0539 

BRD0539 is a cell-permeable and non-toxic inhibitor of CRISPR-Cas9. BRD0539 inhibits Streptococcus pyogenes Cas9 (SpCas9) (apparent IC50=22 μM) in an in vitro DNA cleavage assay.

SCR7 pyrazine

SCR7 pyrazine is reported to be an inhibitor of non-homologous end joining (NHEJ) and has been shown to enhance the efficiency of CRISPR-Cas9 genome editing.

  Catalog
Abmole Inhibitor Catalog




Keywords: RS-1 supplier, CRISPR/Cas9, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.